Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

Similar articles for PubMed (Select 21993207)

1.

Pilot randomized clinical trial of an SSRI vs bupropion: effects on suicidal behavior, ideation, and mood in major depression.

Grunebaum MF, Ellis SP, Duan N, Burke AK, Oquendo MA, John Mann J.

Neuropsychopharmacology. 2012 Feb;37(3):697-706. doi: 10.1038/npp.2011.247. Epub 2011 Oct 12.

2.

SSRI versus bupropion effects on symptom clusters in suicidal depression: post hoc analysis of a randomized clinical trial.

Grunebaum MF, Keilp JG, Ellis SP, Sudol K, Bauer N, Burke AK, Oquendo MA, Mann JJ.

J Clin Psychiatry. 2013 Sep;74(9):872-9. doi: 10.4088/JCP.12m08000.

3.

Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.

Zisook S, Lesser IM, Lebowitz B, Rush AJ, Kallenberg G, Wisniewski SR, Nierenberg AA, Fava M, Luther JF, Morris DW, Trivedi MH.

J Clin Psychiatry. 2011 Oct;72(10):1322-32. doi: 10.4088/JCP.10m06724.

PMID:
22075098
4.

Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.

Rucci P, Frank E, Scocco P, Calugi S, Miniati M, Fagiolini A, Cassano GB.

Depress Anxiety. 2011 Apr;28(4):303-9. doi: 10.1002/da.20758. Epub 2011 Feb 9.

5.

Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.

Carpenter DJ, Fong R, Kraus JE, Davies JT, Moore C, Thase ME.

J Clin Psychiatry. 2011 Nov;72(11):1503-14. doi: 10.4088/JCP.08m04927blu. Epub 2011 Feb 22.

PMID:
21367354
6.

Insomnia severity is an indicator of suicidal ideation during a depression clinical trial.

McCall WV, Blocker JN, D'Agostino R Jr, Kimball J, Boggs N, Lasater B, Rosenquist PB.

Sleep Med. 2010 Oct;11(9):822-7. doi: 10.1016/j.sleep.2010.04.004. Epub 2010 May 15.

7.

Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.

Papakostas GI, Nutt DJ, Hallett LA, Tucker VL, Krishen A, Fava M.

Biol Psychiatry. 2006 Dec 15;60(12):1350-5. Epub 2006 Aug 24. Review.

PMID:
16934768
8.
9.

[Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].

Hjalmarsson L, Corcos M, Jeammet P.

Encephale. 2005 May-Jun;31(3):309-16. French.

PMID:
16142045
10.

Decreased suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors: an open study.

Sher L, Stanley BH, Posner K, Arendt M, Grunebaum MF, Neria Y, Mann JJ, Oquendo MA.

Psychiatry Res. 2012 Apr 30;196(2-3):261-6. doi: 10.1016/j.psychres.2011.11.010. Epub 2012 Mar 6.

11.

Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion.

Gorlyn M, Keilp J, Burke A, Oquendo M, Mann JJ, Grunebaum M.

Psychiatry Res. 2015 Feb 28;225(3):407-12. doi: 10.1016/j.psychres.2014.12.004. Epub 2014 Dec 13.

PMID:
25555415
12.

Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy.

Kraus JE, Horrigan JP, Carpenter DJ, Fong R, Barrett PS, Davies JT.

J Affect Disord. 2010 Jan;120(1-3):40-7. doi: 10.1016/j.jad.2009.04.004. Epub .

PMID:
19439363
13.

Sexual function during bupropion or paroxetine treatment of major depressive disorder.

Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S.

Can J Psychiatry. 2006 Mar;51(4):234-42.

PMID:
16629348
14.

The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.

Sung SC, Haley CL, Wisniewski SR, Fava M, Nierenberg AA, Warden D, Morris DW, Kurian BT, Trivedi MH, Rush AJ; CO-MED Study Team.

J Clin Psychiatry. 2012 Jul;73(7):967-76. doi: 10.4088/JCP.11m07043. Epub 2012 May 29.

PMID:
22687487
15.
16.

Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.

Brent DA, Emslie GJ, Clarke GN, Asarnow J, Spirito A, Ritz L, Vitiello B, Iyengar S, Birmaher B, Ryan ND, Zelazny J, Onorato M, Kennard B, Mayes TL, Debar LL, McCracken JT, Strober M, Suddath R, Leonard H, Porta G, Keller MB.

Am J Psychiatry. 2009 Apr;166(4):418-26. doi: 10.1176/appi.ajp.2008.08070976. Epub 2009 Feb 17.

17.

Suicidal risk during controlled clinical investigations of fluvoxamine.

Letizia C, Kapik B, Flanders WD.

J Clin Psychiatry. 1996 Sep;57(9):415-21.

PMID:
9746450
18.

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.

Weihs KL, Settle EC Jr, Batey SR, Houser TL, Donahue RM, Ascher JA.

J Clin Psychiatry. 2000 Mar;61(3):196-202.

PMID:
10817105
19.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
20.

Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women.

Revicki DA, Siddique J, Frank L, Chung JY, Green BL, Krupnick J, Prasad M, Miranda J.

Arch Gen Psychiatry. 2005 Aug;62(8):868-75.

PMID:
16061764
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk